New Company, MAGiQ, Aims to Develop Stem Cell Therapies for ALS and Like Diseases – ALS News Today
ALS News Today |
New Company, MAGiQ, Aims to Develop Stem Cell Therapies for ALS and Like Diseases
ALS News Today MAGiQ aim to develop glial progenitor cells — supportive cells of the CNS — from induced pluripotent stem cells (iPSCs), which are stem cells derived from differentiated cells. Researchers will create glial-restricted progenitor cells (GRPs) from … |
